QualityStocks'  Instablog

Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • International Stem Cell Corp. (ISCO) Schedules Q2 Earnings Conference Call, Webcast 0 comments
    Aug 2, 2013 10:29 AM | about stocks: ISCO

    California-based biotech company, International Stem Cell, will host a conference call Friday, August 9, 2013, to discuss the company's financial results for the three-month and six-month periods ended June 30, 2013.

    Executive Vice President Dr. Simon Craw and Interim CFO Jay Novak will host the conference call, also available via Web cast. To attend the call, please use the dial in information below:

    Date: Friday, August 9, 2013

    Time: 11 a.m. Eastern Time

    Conference Line (U.S.): 1-877-317-6776

    International Dial-In: 1-412-317-6776

    Conference ID: 10032411

    Webcast: webcast.mzvaluemonitor.com/Cover.aspx?PlatformId=1545

    Please dial in at least 10-minutes before the call to ensure timely participation.

    A playback of the call will be available until 11 a.m. ET August 16, 2013. To listen, call 1-877-344-7529 within the United States or 1-412-317-0088 when calling internationally. Please use the replay pin number 10032411.

    International Stem Cell is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs), thereby avoiding controversial issues associated with the use or destruction of viable human embryos. hpSCs offer the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology (lifelinecelltech.com), as well as stem cell-based skin care products through its subsidiary Lifeline Skin Care (lifelineskincare.com).

    For additional information, visit InternationalStemCell.com

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

    Stocks: ISCO
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.